BRPI1016013A2 - tablete farmacêutico contendo uma cápsula preenchida com líquido. - Google Patents

tablete farmacêutico contendo uma cápsula preenchida com líquido.

Info

Publication number
BRPI1016013A2
BRPI1016013A2 BRPI1016013A BRPI1016013A BRPI1016013A2 BR PI1016013 A2 BRPI1016013 A2 BR PI1016013A2 BR PI1016013 A BRPI1016013 A BR PI1016013A BR PI1016013 A BRPI1016013 A BR PI1016013A BR PI1016013 A2 BRPI1016013 A2 BR PI1016013A2
Authority
BR
Brazil
Prior art keywords
liquid
tablet containing
pharmaceutical tablet
capsule filled
capsule
Prior art date
Application number
BRPI1016013A
Other languages
English (en)
Inventor
Frank Bunick
Harry Sowden
Joseph Luber
Leo B Kriksunov
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BRPI1016013A2 publication Critical patent/BRPI1016013A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
BRPI1016013A 2009-06-29 2010-06-28 tablete farmacêutico contendo uma cápsula preenchida com líquido. BRPI1016013A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22118209P 2009-06-29 2009-06-29
PCT/US2010/040165 WO2011002702A1 (en) 2009-06-29 2010-06-28 Pharmaceutical tablet containing a liquid filled capsule

Publications (1)

Publication Number Publication Date
BRPI1016013A2 true BRPI1016013A2 (pt) 2016-04-26

Family

ID=42575823

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1016013A BRPI1016013A2 (pt) 2009-06-29 2010-06-28 tablete farmacêutico contendo uma cápsula preenchida com líquido.

Country Status (7)

Country Link
US (2) US20100330169A1 (pt)
EP (1) EP2496219A1 (pt)
CN (1) CN102470111A (pt)
BR (1) BRPI1016013A2 (pt)
CA (1) CA2766202A1 (pt)
RU (1) RU2012102772A (pt)
WO (1) WO2011002702A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8102520B2 (en) 2004-06-14 2012-01-24 Ackley Machine Corporation Methods and systems for inspection and/or identification of pellet-shaped articles
KR101762460B1 (ko) 2009-09-24 2017-07-27 캡슈겔 벨지엄 엔브이 내산성 캡슐
CN104411299B (zh) 2012-06-28 2017-11-10 麦克内尔-Ppc股份有限公司 消旋卡多曲类脂组合物
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
CN108777975A (zh) * 2016-01-08 2018-11-09 Can 科技公司 动物饲料丸剂及其制造方法
EP3196315B1 (en) * 2016-01-19 2020-02-05 ORITEST spol. s r.o. Spherical pellets, manufacturing process of such pellets, use, and a detection tube comprising such pellets
CA3029985A1 (en) 2016-07-05 2018-01-11 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Oral dosage form containing a fast release exterior coating
US20200054567A1 (en) * 2016-11-04 2020-02-20 Nova Southeastern University Drug delivery systems and methods for preparation thereof
AU2017364077A1 (en) 2016-11-22 2019-06-20 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
EP3658612A4 (en) 2017-07-25 2021-06-02 Elektrofi, Inc. FORMATION OF PARTICLES WITH SUBSTANCES
WO2019226969A1 (en) 2018-05-24 2019-11-28 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
WO2020160323A2 (en) 2019-01-31 2020-08-06 Elektrofi, Inc. Particle formation and morphology
JP7781743B2 (ja) 2019-09-13 2025-12-08 エレクトロフィ，インコーポレイテッド 疾患の処置のための治療用生物学的作用剤の送達のための組成物及び方法
CN115484934A (zh) 2020-04-17 2022-12-16 伊勒卓菲公司 通过连续液滴形成和脱水形成颗粒的方法
AU2022390208A1 (en) * 2021-11-16 2024-07-04 Kenvue Brands Llc Customizable dosage forms containing simethicone

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5041292A (en) * 1988-08-31 1991-08-20 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US4906478A (en) 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5275822A (en) 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
US5075114A (en) 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2068402C (en) 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
JP3313124B2 (ja) 1991-07-31 2002-08-12 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
DE4240146A1 (en) * 1991-11-28 1993-06-17 Geiger Siegfried Inserting microcapsules contg. pharmaceutical or technical active agents in carrier mass - useful, e.g., in prodn. of retard forms of pharmaceutical active agents
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6113945A (en) * 1996-02-26 2000-09-05 L. Perrigo Company Multi-colored medicament
AU722289B2 (en) * 1996-10-01 2000-07-27 Aptalis Pharmatech, Inc. Taste-masked microcapsule compositions and methods of manufacture
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
JP3667045B2 (ja) 1997-09-10 2005-07-06 森下仁丹株式会社 口臭除去用多重ソフトカプセルおよびその製造法
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US7217381B2 (en) * 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6767200B2 (en) 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6949256B2 (en) 2002-01-18 2005-09-27 Banner Pharmacaps, Inc. Non-gelatin capsule shell formulation
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
AU2003301121A1 (en) * 2002-12-18 2004-07-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
EP2359817B1 (en) * 2003-03-28 2018-01-10 Sigmoid Pharma Limited Solid oral dosage form containing seamless microcapsules
DE10337814B4 (de) * 2003-08-14 2015-12-31 Budich International Gmbh Mehrphasige Wasch-, Putz-oder Körperpflegemitteltablette
US20050053655A1 (en) * 2003-09-05 2005-03-10 Pharmaceutical Industry Technology And Development Center Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
US7578951B2 (en) 2004-01-27 2009-08-25 Hewlett-Packard Development Company, L.P. Method of making microcapsules utilizing a fluid ejector
WO2007112747A1 (en) * 2006-03-31 2007-10-11 Curalogic A/S Immunogen combinations
US20080075766A1 (en) * 2006-09-25 2008-03-27 Shun-Por Li Multi-core dosage form having transparent outer coating

Also Published As

Publication number Publication date
US20160346215A1 (en) 2016-12-01
EP2496219A1 (en) 2012-09-12
US20100330169A1 (en) 2010-12-30
CN102470111A (zh) 2012-05-23
CA2766202A1 (en) 2011-01-06
RU2012102772A (ru) 2013-08-10
WO2011002702A1 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
BRPI1016013A2 (pt) tablete farmacêutico contendo uma cápsula preenchida com líquido.
CY2020008I1 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
BR112012011902A2 (pt) cápsula farmacêutica
EP2429506A4 (en) DOSAGE FOR COATED PHARMACEUTICAL CAPSULES
BRPI1012246A2 (pt) composição farmacêutica contendo um fármaco e sirna
HUE048820T2 (hu) Adagkapszula vonalkóddal
BRPI1008900A2 (pt) mecanismo de recipiente e de distribuição de fármaco
ATE508073T1 (de) Kapselbehälter
ZA201006029B (en) Pharmaceutical dosage form
ZA201304709B (en) A pharmaceutical dosage form
IL208335A0 (en) Chid-resistant medication container
BRPI0817631A2 (pt) Dispositivo para adicionar um medicamento a uma solução de infusão em um recipiente de infusão
BR112013007256A2 (pt) sistema de preparação de bebida a partir de um produto de difusão contido em uma cápsula intercambiável.
PT2376147T (pt) Recipiente para fármaco melhorado
IL235704A0 (en) Unitary packaging for one container filled with a liquid pharmaceutical product
IT1394027B1 (it) Macchina per il riempimento di capsule con prodotti farmaceutici
ZA200903858B (en) Pharmaceutical dosage form
DK2238049T3 (da) Kapsel til infusionsdrikke
IL219617A0 (en) Pharmaceutical solid dosage form
PL2435010T3 (pl) Stacja przygotowywania leków
DK2648785T3 (da) Manipulationsafslørende indikator til en lægemiddelbeholder
IL218224A0 (en) Medicament container
EP2476413A4 (en) LIQUID COMPOSITION FOR FILLING IN SOFT CAPSULES
IL217418A0 (en) Medicament container
PL2651390T3 (pl) Orodyspersyjna tabletka farmaceutyczna na bazie zolpidemu

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired